{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:03:25Z","timestamp":1794373405716,"version":"4.9.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Regulatory T cells (Tregs) are crucial in controlling allospecific immune responses. However, studies in human kidney recipients regarding the contribution of polyspecific Tregs have provided differing results and studies on alloreactive Tregs are missing completely. In this retrospective study, we specifically analyzed activated CD4<jats:sup>+<\/jats:sup>CD25<jats:sup>high<\/jats:sup>FOXP3<jats:sup>+<\/jats:sup>GARP<jats:sup>+<\/jats:sup>Tregs in 17 patients of a living donor kidney transplantation cohort longitudinally over 24 months by flow cytometry (FOXP3: forkhead box protein 3, GARP: glycoprotein A repetitions predominant). We could demonstrate that Tregs of patients with end-stage renal disease (ESRD) are already pre-activated when compared to healthy controls. Furthermore, even though total CD4<jats:sup>+<\/jats:sup>CD25<jats:sup>high<\/jats:sup>FOXP3<jats:sup>+<\/jats:sup>Treg numbers decreased in the first three months after transplantation, frequency of activated Tregs increased significantly representing up to 40% of all peripheral Tregs. In a cohort of living donor kidney transplantation recipients with stable graft function, frequencies of activated Tregs did not correlate with the occurrence of acute cellular rejection or chronic graft dysfunction. Our results will be important for clinical trials using adoptive Treg therapy after kidney transplantation. Adoptively transferred Tregs could be important to compensate the Treg loss at month 3, while they have to compete within the Treg niche with a large number of activated Tregs.<\/jats:p>","DOI":"10.1038\/s41598-018-37218-x","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T11:04:33Z","timestamp":1548932673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Transient increase of activated regulatory T cells early after kidney transplantation"],"prefix":"10.1038","volume":"9","author":[{"given":"Young-Seon","family":"Mederacke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian W.","family":"Vondran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Kollrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Schulde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Klempnauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Schwinzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Noyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar","family":"Jaeckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,31]]},"reference":[{"key":"37218_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ni1178","volume":"6","author":"S Sakaguchi","year":"2005","unstructured":"Sakaguchi, S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6, 345\u2013352, https:\/\/doi.org\/10.1038\/ni1178 (2005).","journal-title":"Nat Immunol"},{"key":"37218_CR2","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/nm915","volume":"9","author":"M Edinger","year":"2003","unstructured":"Edinger, M. et al. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 9, 1144\u20131150, https:\/\/doi.org\/10.1038\/nm915 (2003).","journal-title":"Nat Med"},{"key":"37218_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ajt.12509","volume":"14","author":"K Lee","year":"2014","unstructured":"Lee, K., Nguyen, V., Lee, K. M., Kang, S. M. & Tang, Q. Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy. Am J Transplant 14, 27\u201338, https:\/\/doi.org\/10.1111\/ajt.12509 (2014).","journal-title":"Am J Transplant"},{"key":"37218_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nm1688","volume":"14","author":"O Joffre","year":"2008","unstructured":"Joffre, O. et al. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med 14, 88\u201392, https:\/\/doi.org\/10.1038\/nm1688 (2008).","journal-title":"Nat Med"},{"key":"37218_CR5","doi-asserted-by":"crossref","unstructured":"Jaeckel, E., von Boehmer, H. & Manns, M. P. Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes. Diabetes 54, 306-310, 54.02.04.db04-1252 (2005).","DOI":"10.2337\/diabetes.54.2.306"},{"key":"37218_CR6","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1002\/eji.201344381","volume":"44","author":"F Noyan","year":"2014","unstructured":"Noyan, F. et al. Isolation of human antigen-specific regulatory T cells with high suppressive function. Eur J Immunol 44, 2592\u20132602, https:\/\/doi.org\/10.1002\/eji.201344381 (2014).","journal-title":"Eur J Immunol"},{"key":"37218_CR7","doi-asserted-by":"publisher","unstructured":"Noyan, F. et al. Prevention of allograft rejection by use of regulatory T cells with a MHC-specific chimeric antigen receptor. Am J Transplant, https:\/\/doi.org\/10.1111\/ajt.14175 (2016).","DOI":"10.1111\/ajt.14175"},{"key":"37218_CR8","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1084\/jem.20040139","volume":"199","author":"Q Tang","year":"2004","unstructured":"Tang, Q. et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199, 1455\u20131465, https:\/\/doi.org\/10.1084\/jem.20040139 (2004).","journal-title":"J Exp Med"},{"key":"37218_CR9","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1172\/JCI33185","volume":"118","author":"JY Tsang","year":"2008","unstructured":"Tsang, J. Y. et al. Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. J Clin Invest 118, 3619\u20133628, https:\/\/doi.org\/10.1172\/JCI33185 (2008).","journal-title":"J Clin Invest"},{"key":"37218_CR10","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1097\/TP.0000000000001757","volume":"101","author":"AJ Lam","year":"2017","unstructured":"Lam, A. J., Hoeppli, R. E. & Levings, M. K. Harnessing Advances in T Regulatory Cell Biology for Cellular Therapy in Transplantation. Transplantation 101, 2277\u20132287, https:\/\/doi.org\/10.1097\/TP.0000000000001757 (2017).","journal-title":"Transplantation"},{"key":"37218_CR11","first-page":"91","volume":"75","author":"D Kollins","year":"2011","unstructured":"Kollins, D. et al. FOXP3+ regulatory T-cells in renal allografts: correlation with long-term graft function and acute rejection. Clin Nephrol 75, 91\u2013100 (2011).","journal-title":"Clin Nephrol"},{"key":"37218_CR12","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/j.1600-6143.2008.02268.x","volume":"8","author":"S Bunnag","year":"2008","unstructured":"Bunnag, S. et al. FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am J Transplant 8, 1423\u20131433, https:\/\/doi.org\/10.1111\/j.1600-6143.2008.02268.x (2008).","journal-title":"Am J Transplant"},{"key":"37218_CR13","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/j.1600-6143.2006.01704.x","volume":"7","author":"F Veronese","year":"2007","unstructured":"Veronese, F. et al. Pathological and clinical correlates of FOXP3+ cells in renal allografts during acute rejection. Am J Transplant 7, 914\u2013922, https:\/\/doi.org\/10.1111\/j.1600-6143.2006.01704.x (2007).","journal-title":"Am J Transplant"},{"key":"37218_CR14","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1681\/ASN.2007111174","volume":"19","author":"O Bestard","year":"2008","unstructured":"Bestard, O. et al. Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol 19, 2020\u20132026, https:\/\/doi.org\/10.1681\/ASN.2007111174 (2008).","journal-title":"J Am Soc Nephrol"},{"key":"37218_CR15","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1111\/j.1600-6143.2011.03633.x","volume":"11","author":"O Bestard","year":"2011","unstructured":"Bestard, O. et al. Intragraft regulatory T cells in protocol biopsies retain foxp3 demethylation and are protective biomarkers for kidney graft outcome. Am J Transplant 11, 2162\u20132172, https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03633.x (2011).","journal-title":"Am J Transplant"},{"key":"37218_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/01.tp.0000248884.71946.19","volume":"83","author":"P Grimbert","year":"2007","unstructured":"Grimbert, P. et al. The regulatory\/cytotoxic graft-infiltrating T cells differentiate renal allograft borderline change from acute rejection. Transplantation 83, 341\u2013346, https:\/\/doi.org\/10.1097\/01.tp.0000248884.71946.19 (2007).","journal-title":"Transplantation"},{"key":"37218_CR17","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1681\/ASN.2008030254","volume":"19","author":"H Mansour","year":"2008","unstructured":"Mansour, H. et al. Intragraft levels of Foxp3 mRNA predict progression in renal transplants with borderline change. J Am Soc Nephrol 19, 2277\u20132281, https:\/\/doi.org\/10.1681\/ASN.2008030254 (2008).","journal-title":"J Am Soc Nephrol"},{"key":"37218_CR18","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1681\/ASN.2008050450","volume":"20","author":"J Ashton-Chess","year":"2009","unstructured":"Ashton-Chess, J. et al. Regulatory, effector, and cytotoxic T cell profiles in long-term kidney transplant patients. J Am Soc Nephrol 20, 1113\u20131122, https:\/\/doi.org\/10.1681\/ASN.2008050450 (2009).","journal-title":"J Am Soc Nephrol"},{"key":"37218_CR19","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/j.1432-2277.2007.00537.x","volume":"20","author":"C Braudeau","year":"2007","unstructured":"Braudeau, C. et al. Variation in numbers of CD4+CD25highFOXP3+T cells with normal immuno-regulatory properties in long-term graft outcome. Transpl Int 20, 845\u2013855, https:\/\/doi.org\/10.1111\/j.1432-2277.2007.00537.x (2007).","journal-title":"Transpl Int"},{"key":"37218_CR20","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1097\/01.ASN.0000067411.03024.A9","volume":"14","author":"D Game","year":"2003","unstructured":"Game, D., Hernandez-Fuentes, M., Chaudhry, A. & Lechler, R. CD4+CD25+ regulatory T cells do not significantly contribute to direct pathway hyporesponsiveness in stable renal transplant patients. J Am Soc Nephrol 14, 1652\u20131661 (2003).","journal-title":"J Am Soc Nephrol"},{"key":"37218_CR21","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/01.tp.0000203166.44968.86","volume":"81","author":"S Louis","year":"2006","unstructured":"Louis, S. et al. Contrasting CD25hiCD4+T cells\/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 81, 398\u2013407, https:\/\/doi.org\/10.1097\/01.tp.0000203166.44968.86 (2006).","journal-title":"Transplantation"},{"key":"37218_CR22","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1111\/j.1600-6143.2006.01566.x","volume":"6","author":"JH Velthuis","year":"2006","unstructured":"Velthuis, J. H., Mol, W. M., Weimar, W. & Baan, C. C. CD4+CD25bright+regulatory T cells can mediate donor nonreactivity in long-term immunosuppressed kidney allograft patients. Am J Transplant 6, 2955\u20132964 (2006).","journal-title":"Am J Transplant"},{"key":"37218_CR23","doi-asserted-by":"publisher","first-page":"13445","DOI":"10.1073\/pnas.0901944106","volume":"106","author":"D Tran","year":"2009","unstructured":"Tran, D. et al. GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells. Proc Natl Acad Sci USA 106, 13445\u201313450, https:\/\/doi.org\/10.1073\/pnas.0901944106 (2009).","journal-title":"Proc Natl Acad Sci USA"},{"key":"37218_CR24","doi-asserted-by":"publisher","first-page":"973","DOI":"10.4049\/jimmunol.166.2.973","volume":"166","author":"E Suchin","year":"2001","unstructured":"Suchin, E. et al. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol 166, 973\u2013981 (2001).","journal-title":"J Immunol"},{"key":"37218_CR25","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.2215\/CJN.12931212","volume":"8","author":"B Afzali","year":"2013","unstructured":"Afzali, B. et al. Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation. Clin J Am Soc Nephrol 8, 1396\u20131405, https:\/\/doi.org\/10.2215\/CJN.12931212 (2013).","journal-title":"Clin J Am Soc Nephrol"},{"key":"37218_CR26","doi-asserted-by":"publisher","first-page":"e105422","DOI":"10.1371\/journal.pone.0105422","volume":"9","author":"M Baron","year":"2014","unstructured":"Baron, M. et al. Innate-like and conventional T cell populations from hemodialyzed and kidney transplanted patients are equally compromised. PLoS One 9, e105422, https:\/\/doi.org\/10.1371\/journal.pone.0105422 (2014).","journal-title":"PLoS One"},{"key":"37218_CR27","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/ndt\/gfp005","volume":"24","author":"TK Hendrikx","year":"2009","unstructured":"Hendrikx, T. K. et al. End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+T-cells. Nephrol Dial Transplant 24, 1969\u20131978, https:\/\/doi.org\/10.1093\/ndt\/gfp005 (2009).","journal-title":"Nephrol Dial Transplant"},{"key":"37218_CR28","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/ndt\/gfq055","volume":"25","author":"C Libetta","year":"2010","unstructured":"Libetta, C. et al. Dialysis treatment and regulatory T cells. Nephrol Dial Transplant 25, 1723\u20131727, https:\/\/doi.org\/10.1093\/ndt\/gfq055 (2010).","journal-title":"Nephrol Dial Transplant"},{"key":"37218_CR29","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s11255-013-0460-9","volume":"45","author":"C Topal","year":"2013","unstructured":"Topal, C., Koksoy, S., Suleymanlar, G., Yakuboglu, G. & Fevzi Ersoy, F. Peripheral Treg count and it\u2019s determinants in unsensitized and sensitized chronic kidney disease patients. Int Urol Nephrol 45, 1647\u20131652, https:\/\/doi.org\/10.1007\/s11255-013-0460-9 (2013).","journal-title":"Int Urol Nephrol"},{"key":"37218_CR30","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1111\/j.1600-6143.2008.02377.x","volume":"8","author":"JA Bluestone","year":"2008","unstructured":"Bluestone, J. A. et al. The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation. Am J Transplant 8, 2086\u20132096, https:\/\/doi.org\/10.1111\/j.1600-6143.2008.02377.x (2008).","journal-title":"Am J Transplant"},{"key":"37218_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.trim.2015.07.005","volume":"33","author":"C Libetta","year":"2015","unstructured":"Libetta, C. et al. Sirolimus vs cyclosporine after induction with basiliximab does not promote regulatory T cell expansion in de novo kidney transplantation: Results from a single-center randomized trial. Transpl Immunol 33, 117\u2013124, https:\/\/doi.org\/10.1016\/j.trim.2015.07.005 (2015).","journal-title":"Transpl Immunol"},{"key":"37218_CR32","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1399-0012.2009.01086.x","volume":"24","author":"D San Segundo","year":"2010","unstructured":"San Segundo, D. et al. Two-year follow-up of a prospective study of circulating regulatory T cells in renal transplant patients. Clin Transplant 24, 386\u2013393, https:\/\/doi.org\/10.1111\/j.1399-0012.2009.01086.x (2010).","journal-title":"Clin Transplant"},{"key":"37218_CR33","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1432-2277.2009.01013.x","volume":"23","author":"FW Vondran","year":"2010","unstructured":"Vondran, F. W. et al. Impact of Basiliximab on regulatory T-cells early after kidney transplantation: down-regulation of CD25 by receptor modulation. Transpl Int 23, 514\u2013523, https:\/\/doi.org\/10.1111\/j.1432-2277.2009.01013.x (2010).","journal-title":"Transpl Int"},{"key":"37218_CR34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1681\/ASN.2009060628","volume":"21","author":"A Nakorchevsky","year":"2010","unstructured":"Nakorchevsky, A. et al. Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies. J Am Soc Nephrol 21, 362\u2013373, https:\/\/doi.org\/10.1681\/ASN.2009060628 (2010).","journal-title":"J Am Soc Nephrol"},{"key":"37218_CR35","doi-asserted-by":"publisher","first-page":"852395","DOI":"10.1155\/2013\/852395","volume":"2013","author":"O Franzese","year":"2013","unstructured":"Franzese, O. et al. Regulatory T cells in the immunodiagnosis and outcome of kidney allograft rejection. Clin Dev Immunol 2013, 852395, https:\/\/doi.org\/10.1155\/2013\/852395 (2013).","journal-title":"Clin Dev Immunol"},{"key":"37218_CR36","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.4049\/jimmunol.162.9.5317","volume":"162","author":"M Itoh","year":"1999","unstructured":"Itoh, M. et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 162, 5317\u20135326 (1999).","journal-title":"J Immunol"},{"key":"37218_CR37","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nri2200","volume":"7","author":"N Felix","year":"2007","unstructured":"Felix, N. & Allen, P. Specificity of T-cell alloreactivity. Nat Rev Immunol 7, 942\u2013953, https:\/\/doi.org\/10.1038\/nri2200 (2007).","journal-title":"Nat Rev Immunol"},{"key":"37218_CR38","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/ni1446","volume":"8","author":"N Felix","year":"2007","unstructured":"Felix, N. et al. Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes. Nat Immunol 8, 388\u2013397, https:\/\/doi.org\/10.1038\/ni1446 (2007).","journal-title":"Nat Immunol"},{"key":"37218_CR39","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.smim.2007.02.012","volume":"19","author":"K Wucherpfennig","year":"2007","unstructured":"Wucherpfennig, K. et al. Polyspecificity of T cell and B cell receptor recognition. Semin Immunol 19, 216\u2013224, https:\/\/doi.org\/10.1016\/j.smim.2007.02.012 (2007).","journal-title":"Semin Immunol"},{"key":"37218_CR40","doi-asserted-by":"publisher","first-page":"13439","DOI":"10.1073\/pnas.0901965106","volume":"106","author":"R Wang","year":"2009","unstructured":"Wang, R. et al. Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells. Proc Natl Acad Sci USA 106, 13439\u201313444, https:\/\/doi.org\/10.1073\/pnas.0901965106 (2009).","journal-title":"Proc Natl Acad Sci USA"},{"key":"37218_CR41","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.4049\/jimmunol.1003099","volume":"186","author":"S McClymont","year":"2011","unstructured":"McClymont, S. et al. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J Immunol 186, 3918\u20133926, https:\/\/doi.org\/10.4049\/jimmunol.1003099 (2011).","journal-title":"J Immunol"},{"key":"37218_CR42","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1182\/blood-2011-02-337097","volume":"118","author":"A Veerapathran","year":"2011","unstructured":"Veerapathran, A., Pidala, J., Beato, F., Yu, X. & Anasetti, C. Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly. Blood 118, 5671\u20135680, https:\/\/doi.org\/10.1182\/blood-2011-02-337097 (2011).","journal-title":"Blood"},{"key":"37218_CR43","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1056\/NEJMoa051907","volume":"353","author":"T Muthukumar","year":"2005","unstructured":"Muthukumar, T. et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 353, 2342\u20132351, https:\/\/doi.org\/10.1056\/NEJMoa051907 (2005).","journal-title":"N Engl J Med"},{"key":"37218_CR44","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/j.1399-0012.2010.01354.x","volume":"25","author":"F Vondran","year":"2011","unstructured":"Vondran, F. et al. Association of high anti-donor alloreactivity and low frequency of FoxP3-expressing cells prior to kidney transplantation with acute graft rejection. Clin Transplant 25, 905\u2013914, https:\/\/doi.org\/10.1111\/j.1399-0012.2010.01354.x (2011).","journal-title":"Clin Transplant"},{"key":"37218_CR45","doi-asserted-by":"publisher","unstructured":"Salman, J. et al. Association of higher CD4(+) CD25(high) CD127(low), FoxP3(+), and IL-2(+) T cell frequencies early after lung transplantation with less chronic lung allograft dysfunction at two years. Am J Transplant, https:\/\/doi.org\/10.1111\/ajt.14148 (2016).","DOI":"10.1111\/ajt.14148"},{"key":"37218_CR46","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.humimm.2018.01.007","volume":"79","author":"JR Leventhal","year":"2018","unstructured":"Leventhal, J. R. & Ildstad, S. T. Tolerance induction in HLA disparate living donor kidney transplantation by facilitating cell-enriched donor stem cell Infusion: The importance of durable chimerism. Hum Immunol 79, 272\u2013276, https:\/\/doi.org\/10.1016\/j.humimm.2018.01.007 (2018).","journal-title":"Hum Immunol"},{"key":"37218_CR47","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/ajt.13416","volume":"16","author":"JR Leventhal","year":"2016","unstructured":"Leventhal, J. R. et al. Nonchimeric HLA-Identical Renal Transplant Tolerance: Regulatory Immunophenotypic\/Genomic Biomarkers. Am J Transplant 16, 221\u2013234, https:\/\/doi.org\/10.1111\/ajt.13416 (2016).","journal-title":"Am J Transplant"},{"key":"37218_CR48","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1681\/ASN.2004100824","volume":"16","author":"CL Davis","year":"2005","unstructured":"Davis, C. L. & Delmonico, F. L. Living-donor kidney transplantation: a review of the current practices for the live donor. J Am Soc Nephrol 16, 2098\u20132110, https:\/\/doi.org\/10.1681\/ASN.2004100824 (2005).","journal-title":"J Am Soc Nephrol"},{"key":"37218_CR49","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1111\/ajt.12433","volume":"13","author":"AL Putnam","year":"2013","unstructured":"Putnam, A. L. et al. Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation. Am J Transplant 13, 3010\u20133020, https:\/\/doi.org\/10.1111\/ajt.12433 (2013).","journal-title":"Am J Transplant"},{"key":"37218_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25574-7","volume":"8","author":"JM Mathew","year":"2018","unstructured":"Mathew, J. M. et al. A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants. Sci Rep 8, 7428, https:\/\/doi.org\/10.1038\/s41598-018-25574-7 (2018).","journal-title":"Sci Rep"},{"key":"37218_CR51","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.humimm.2017.12.013","volume":"79","author":"K Kawai","year":"2018","unstructured":"Kawai, K., Uchiyama, M., Hester, J., Wood, K. & Issa, F. Regulatory T cells for tolerance. Hum Immunol 79, 294\u2013303, https:\/\/doi.org\/10.1016\/j.humimm.2017.12.013 (2018).","journal-title":"Hum Immunol"},{"key":"37218_CR52","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1111\/ajt.14415","volume":"17","author":"S Chandran","year":"2017","unstructured":"Chandran, S. et al. Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants. Am J Transplant 17, 2945\u20132954, https:\/\/doi.org\/10.1111\/ajt.14415 (2017).","journal-title":"Am J Transplant"},{"key":"37218_CR53","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","volume":"8","author":"K Solez","year":"2008","unstructured":"Solez, K. et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 8, 753\u2013760, https:\/\/doi.org\/10.1111\/j.1600-6143.2008.02159.x (2008).","journal-title":"Am J Transplant"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37218-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37218-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37218-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T09:35:02Z","timestamp":1694597702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37218-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,31]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["37218"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-37218-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,31]]},"assertion":[{"value":"23 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1021"}}